http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103688174-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78f8022b80814c648575edadf0e3d6eb |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S128-921 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2012-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffd8604d613af544f149a043e6ef10ce |
publicationDate | 2014-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103688174-A |
titleOfInvention | Compositions and methods for personal tumor profiling treatment |
abstract | The present invention discloses therapeutic compositions and methods for treating a patient having a tumor disease. Methods and dietary compositions thereof for determining a diet regime for a patient with a tumor disease include the steps of: providing a sample of the patient; profiling at least one biochemical parameter of the sample using a biochemical analyzer to obtain a profile; identifying a biologically-active molecular feature of the profile; correlating the feature with a biochemical pathway related to the tumor's metabolism or proliferation; determining the diet regime specific to the patient, wherein the diet regime includes at least one biologically-active molecule corresponding to the feature of the profile; and administering the diet regime to the patient in a therapeutically-effective dosage. Preferably, the sample is selected from the group consisting of: a tumor sample, biological tissue, an organ sample, blood, blood serum, blood plasma, and urine. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111686248-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115372604-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106722973-A |
priorityDate | 2011-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 275.